Adjuvant progestagen therapy for the treatment of endometrial cancer: Review and meta-analyses of published randomised controlled trials

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 65, Issue 2, 1996, Pages 201-207

  Martin Hirsch, P L ^a   Lilford, R J ^a   Jarvis, G J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Endometrial cancer; Meta analysis; Progestagen; Randomised controlled trial; Review

Indexed keywords

GESTAGEN;

ADJUVANT THERAPY; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; ENDOMETRIUM CANCER; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

EID: 0029885706     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(95)02359-3     Document Type: Review

References (12)

1. Kauppila A, Gronroos M, Niemineu U. Clinical outcome of endometrial cancer. Obstet Gynecol 1982; 60: 473.
2. Morrow CP, Disaia PJ, Townsend DE. Current management of endometrial cancer. Obstet Gynaecol 1973; 60: 339.
3. Lotocki RJ, Copeland LJ, DePetrillo AD, Muirhead W. Stage 1 endometrial adenocarcinoma: treatment results in 835 patients. Am J Obstet Gynecol 1984; 146: 141.
4. Schultz K, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. J Am Med Assoc 1995; 273: 408-412.
5. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
6. MacDonald RR, Thorogood J, Mason MK. A randomised trial of progestagens in the primary treatment of endometrial carcinoma. Br J Obstet Gynecol 1988; 95: 166-174.
7. Depalo G, Mangioni C, Periti P, Del Vecchio M, Marubini E. Treatment of FIGO (1971) Stage 1 endometrial carcinoma with intensive surgery, radiotherapy, and hormonotherapy according to pathological prognostic groups. Long term results of a randomised multicentre trial. Cancer 1993; 29a: 113-140.
8. Lewis GC, Slack NH, Mortel R, Bross I. Adjuvant progestagen therapy in the definitive treatment of endometrial cancer. Gynecol Oncol 1974; 2: 368-376.
9. Malkasian G, Decker D. Adjuvant progesterone therapy for Stage 1 endometrial cancer. Int J Gyneacol Obstet 16: 48-49.
10. Vergote I, Kjorstad K, Abeler V, Kolstad P. A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer 1989; 64: 1011-1016.
11. Urbanski K, Karolewski K, Kojs Z, Klimek M, Dyba T. Adjuvant progestagen therapy improves survival in patients with endometrial cancer after hysterectomy. Results of one institutional prospective clinical trial. Eur J Gynecol Oncol 1993; 14 suppl: 98-104.
12. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized controlled trials. Stat Med 1991; 10: 1665-1677.